BUSINESS
Glenmark Pharma soars as its arm receives USFDA’s approval for Lacosamide Tablets
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at…
Glenmark Pharma is currently trading at Rs. 454.35, up by 10.45 points or 2.35% from its previous closing of Rs. 443.90 on the BSE. The scrip opened at…
Glenmark Pharmaceuticals is currently trading at Rs. 533.95, up by 10.30 points or 1.97% from its previous closing of Rs. 523.65 on…
Glenmark Pharmaceuticals has reported results for second quarter ended September 30, 2018. The company has reported over 2-fold jump in its net…